Use of a combination of Myxoma virus and rapamycin for therapeutic treatment

Details for Australian Patent Application No. 2006222500 (hide)

Owner Robarts Research Institute

Inventors Stanford, Marianne; McFadden, Grant; Barrett, John

Agent FB Rice

Pub. Number AU-B-2006222500

PCT Pub. Number WO2006/094385

Priority 60/658,816 07.03.05 US

Filing date 6 March 2006

Wipo publication date 14 September 2006

Acceptance publication date 1 September 2011

International Classifications

C12N 7/02 (2006.01) Viruses, e.g. bacteriophages - Recovery or purification

A61K 31/436 (2006.01)

A61K 35/76 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61K 39/275 (2006.01) Medicinal preparations containing antigens or antibodies - Poxviridae, e.g. avipoxvirus

C12Q 1/04 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - Determining presence or kind of micro-organism

Event Publications

6 September 2007 PCT application entered the National Phase

  PCT publication WO2006/094385 Priority application(s): WO2006/094385

1 September 2011 Application Accepted

  Published as AU-B-2006222500

12 January 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006222502-High alcohol content foaming compositions with silicone-based surfactants

2006222491-Multiple-bit driver with spring-loaded actuation